TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients

Author(s):
Zom, G.G.; Welters, M.J.P.; Loof, N.M.; Goedemans, R.; Lougheed, S.; Valentijn, R.R.P.M.; Zandvliet, M.L.; Meeuwenoord, N.J.; Melief, C.J.M.; Gruijl, T.D. de; Marel, G.A. van der; Filippov, D.V.; Ossendorp, F.; Burg, S.H. van der (0000-0002-6556-0354)
Published
2016
Publication type
Article / Letter to editor
Toll-like receptor ligandconjugatesynthetic long peptidecancer vaccinecervical cancer
Date issued
2016-10-11
Language
English
Is part of
Oncotarget (2016), Vol. 7, no. 41, p. 67087-67100
hdl
1887/111783
doi
10.18632/oncotarget.11512